Brief: Avenue Therapeutics Says Joseph Vazzano Resigning From His Role As CFO
Jan 7 (Reuters) - Avenue Therapeutics Inc ATXI.O :
* AVENUE THERAPEUTICS INC - ON JAN 5, 2022, JOSEPH VAZZANO
NOTIFIED CO THAT HE WAS RESIGNING FROM HIS ROLE AS CO'S CFO,
EFFECTIVE JAN 14, 2022
* AVENUE THERAPEUTICS INC - VAZZANO DID NOT RESIGN AS A
RESULT OF
ANY DISAGREEMENT WITH THE COMPANY
* AVENUE THERAPEUTICS INC - ON JAN 7, 2022 CO APPOINTED LUCY
LU,
AS CO'S INTERIM CHIEF FINANCIAL OFFICER AND PRINCIPAL FINANCIAL
OFFICER
Source: (https://bit.ly/3F5orUj)
Further company coverage: ATXI.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Avenue Therapeutics
See all newsBrief: Axsome Therapeutics Acquires AZD7325, A Selective GABA-A Modulator For Treatment Of Epilepsy
Avenue Therapeutics Inc expected to post a loss of 57 cents a share - Earnings Preview
Brief: Avenue Therapeutics Annji Intends To Terminate License Agreement With Co
Brief: Avenue Therapeutics Receives Delist Letter From Nasdaq Under Nasdaq Listing Rule 5550(B)(1)
Avenue Therapeutics Inc reports results for the quarter ended September 30 - Earnings Summary